Biggest News Aggregation in the World
📰 Beigene News

Page 14 - Beigene News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.

BeiGene to Present Final PFS Results from ALPINE Trial Demonstrating Superior PFS for BRUKINSA Versus IMBRUVICA in Late-Breaking Oral Session at ASH 2022

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235) a global biotechnology company, today announced that the results of the final progression free survival (PFS) analysis of the ALPINE trial will be presented
United States United Kingdom South Korea Mehrdad Mobasher Kevin Mannix Kyle Blankenship

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BeiGene Receives Positive CHMP Opinion for BRUKINSA (zanubrutinib) for the Treatment of Adults With CLL

14.10.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing innovative and affordable oncology medicines to improve treatment outcomes and access for patients worldwide, today announced that the Committee ... Seite 1
United States New Zealand Mehrdad Mobasher Clemens Wendtner University Of Munich European Medicines Agency

BeiGene Announces Positive Topline Results from Final Progression-Free Survival Analysis of BRUKINSA (zanubrutinib) Compared to IMBRUVICA (ibrutinib) in Phase 3 Chronic Lymphocytic Leukemia (CLL) Trial

12.10.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing innovative and affordable oncology medicines to improve treatment outcomes and access for patients worldwide, today announced that BRUKINSA ... Seite 1
New Drug Application

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science